Ingevity (NYSE:NGVT) Issues Earnings Results, Beats Expectations By $0.66 EPS

Ingevity (NYSE:NGVT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.66, Zacks reports. The business had revenue of $298.80 million during the quarter, compared to the consensus estimate of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. Ingevity updated its FY 2025 guidance to EPS.

Ingevity Stock Down 1.4 %

NYSE NGVT traded down $0.64 on Friday, reaching $46.11. 319,076 shares of the stock traded hands, compared to its average volume of 223,149. Ingevity has a 12 month low of $30.90 and a 12 month high of $56.29. The company has a market cap of $1.68 billion, a price-to-earnings ratio of -3.89 and a beta of 1.64. The company has a fifty day moving average price of $43.33 and a 200-day moving average price of $41.09. The company has a debt-to-equity ratio of 6.86, a quick ratio of 1.04 and a current ratio of 1.87.

Analysts Set New Price Targets

A number of brokerages recently issued reports on NGVT. StockNews.com raised Ingevity from a "hold" rating to a "buy" rating in a research note on Thursday. BMO Capital Markets lifted their target price on Ingevity from $61.00 to $62.00 and gave the stock a "market perform" rating in a research report on Thursday. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Ingevity presently has an average rating of "Moderate Buy" and a consensus price target of $54.67.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.